Caldwell Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Caldwell Trust's XBI Position: Q1 2026 in Review
Caldwell Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 660 shares worth $84.3K. The position accounts for 0.01% of the portfolio, ranked #426.
Caldwell Trust first reported a position in XBI in Q4 2019 and has held it in 26 quarters since. The position peaked at $214K in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Caldwell Trust held 660 shares of State Street SPDR S&P Biotech ETF worth $84.3K as of Q1 2026.
- Caldwell Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Caldwell Trust's portfolio in Q1 2026, its #426 holding.
- Caldwell Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 26 quarters since.
- Caldwell Trust's State Street SPDR S&P Biotech ETF position peaked at $214K in Q4 2020.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.